Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model

BACKGROUND: Hepatocellular carcinoma (HCC) is among the most common and lethal human cancers worldwide. Despite remarkable advances in treatment, high mortality in HCC patients remains a big challenge. To develop novel therapeutic strategies for HCC is thus urgently needed to improve patient surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Chiao-Fang, Wang, Ting, Wu, Tzu-Hua, Lin, Jia-Hui, Shih, Fu-Ying, Shyu, Woei-Cherng, Jeng, Long-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288802/
https://www.ncbi.nlm.nih.gov/pubmed/32565925
http://dx.doi.org/10.1177/1758835920922034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288802/
https://www.ncbi.nlm.nih.gov/pubmed/32565925
http://dx.doi.org/10.1177/1758835920922034

Ejemplares similares